How Artificial Intelligence Can Address Analytical Challenges in Gene Therapies and Vaccines
Expert panelists share experiences about how to overcome challenges and needs for supporting analytical data in the development of commercial processes for viral-based therapies. How artificial intelligence plays a role in enabling automation for unbiased results to correlate process impact on critical quality attributes.
Live: Thursday, Sept. 26, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until Sept. 26, 2020